Thursday, September 24, 2015 9:07:36 AM
Sep30-Oct2 2015: “EXL's 17th Medical Science Liaison Best Practices Congress”, SanDiego
“Medical Science Liaisons (MSLs) are a vital part of medical affairs teams and, depending on the size of their company, have many interchangeable functions with other medical affairs professionals. Their main role is to support the dissemination of information to key opinion leaders (KOLs) in a way that not only answers essential medical questions but also strengthens product placement and regulatory compliance.”
http://exlevents.com/17th-medical-science-liaison-best-practices-congress
EXL Events: http://exlevents.com/about-us
Agenda: http://exlevents.com/17th-medical-science-liaison-best-practices-congress/agenda
Oct2 8:45–9am: CHAIRPERSON’S RECAP OF DAY2 - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals
Oct2 9-9:45am: “Strategic MSL Leadership to Improve Operations & Achieve Higher Retention of MSL Teams” - Lisa Stepp, PhD, MBA, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Oct2 3-3:45pm CLOSING REMARKS - Lisa Stepp, Sr. Dir./Medical Affairs, Peregrine Pharmaceuticals, Inc.
Faculty(Lisa Stepp, 1 of 18): http://exlevents.com/17th-medical-science-liaison-best-practices-congress/faculty
Oct7 2015: “Perkin Elmer's Annual Imaging User Group Meeting”, Hopkinton MA
http://go.perkinelmer.com/ImagingUserGroupMeetingTSC2015
Track: “Tissue Imaging – Quantitative Pathology Solutions”
Oct7 9:30-12pm Presentation(1 of 6): Using Technology to Inform Clinical Trial Design, Lisa Stepp, PhD, Sr.Dir./Medical Affairs, Peregrine Pharmaceuticals
= = = = = = = = = = = = = = = = =
Lisa Stepp: http://www.linkedin.com/pub/lisa-stepp-phd-mba/a/942/345
Peregrine Pharmaceuticals (Mar2015-curr 7mos), Sr. Dir./Medical Affairs
Gilead Sciences (Jul2012–curr <=assuming in error), Dir. Clinical Research, Oncology & Inflammation Therapeutics
Allos Therapeutics (Jun2010–Jul2012 2.2yrs), Senior Dir./Medical Affairs
Genentech (Aug2003–Jun2010 6.9yrs), Sr. Reg. Mgr., BioOncology, MSLs
Genentech BioOncology (Feb2003–Aug2003 7mos), Medical Science Liaison
Wyeth (Aug2000–Nov2002 2.3yrs), Medical Science Liaison II
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM